Bacterin International Holdings has signed an exclusive agreement with Jeil Medical to distribute Jeil's LeForte craniomaxillfacial surgery system in the U.S. and Canada.
The LeForte system is composed of orthopedic implants used in craniomaxillofacial procedures, including trauma and reconstruction, and complements Bacterin's existing expertise and product offerings in the tissue grafting arena, the companies noted.
Bacterin is planning a beta launch of the LeForte system next month, followed by a full product release during the second quarter of 2012.
The introduction of these products will expand Bacterin's capabilities to include surgical procedures in the facial area, such as cranial and maxillofacial trauma, orthognathic surgery of the midface and mandible, mandibular reconstruction, reconstruction of the chin, and fracture fixation.
Bacterin intends to develop a second generation of the LeForte system to include its proprietary antimicrobial coating technology.
